PDCD1 and glioblastoma: On the other hand, a different study has suggested that the depletion of peripheral macrophages using clodronate liposomes or TAMs using CSF1R inhibitor BLZ945 eliminates the effectiveness of triple therapy comprising oncolytic HSV, anti-CTLA-4, and anti-PD-1 in GBM models.